Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.


Journal

Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000

Informations de publication

Date de publication:
14 May 2024
Historique:
received: 07 03 2024
accepted: 13 04 2024
medline: 14 5 2024
pubmed: 14 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

Meningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres. We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015. 30,223 meningiomas cases were operated on 28,424 patients, in 61 centres. The average number of meningioma operated per year in France was 3,022 (SD ± 122). Meningioma was 3 times more common in women (74.1% vs. 25.9%). The incidence of meningioma increased with age and, mean age at surgery was 58.5 ± 13.9 years. Grade 1, 2, and 3 meningiomas accounted for 83.9%, 13.91% and, 2.19% respectively. There was a significant variability of meningioma grading by institutions, especially for grade 2 which spanned from 5.1% up to 22.4% (p < 0.001). Moreover, the proportion of grade 2 significantly grew over the study period (p < 0.001). There was also a significant variation in grade 1 subtypes diagnosis among the institutions (p < 0.001). 89.05% of the patients had solely one meningioma surgery, 8.52% two and, 2.43% three or more. The number of surgeries was associated to the grade of malignancy (p < 0.001). The incidence of meningioma surgery increased with age and, peaked at 58.5 years. They were predominantly benign with meningothelial subtype being the most common. However, there was a significant variation of grade 1 subtypes diagnosis among the centres involved. The proportion of grade 2 meningioma significantly grew over the study time, on contrary to malignant meningioma proportion, which remained rare and, stable over time around 2%. Likewise, there was a significant variability of grade 2 meningioma rate among the institutions.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Meningioma is one of the most common neoplasm of the central nervous system. To describe the epidemiology of meningioma operated in France and, to assess grading and histopathological variability among the different neurosurgical centres.
METHODS METHODS
We processed the French Brain Tumour Database (FBTDB) to conduct a nationwide population-based study of all histopathologically confirmed meningiomas between 2006 and 2015.
RESULTS RESULTS
30,223 meningiomas cases were operated on 28,424 patients, in 61 centres. The average number of meningioma operated per year in France was 3,022 (SD ± 122). Meningioma was 3 times more common in women (74.1% vs. 25.9%). The incidence of meningioma increased with age and, mean age at surgery was 58.5 ± 13.9 years. Grade 1, 2, and 3 meningiomas accounted for 83.9%, 13.91% and, 2.19% respectively. There was a significant variability of meningioma grading by institutions, especially for grade 2 which spanned from 5.1% up to 22.4% (p < 0.001). Moreover, the proportion of grade 2 significantly grew over the study period (p < 0.001). There was also a significant variation in grade 1 subtypes diagnosis among the institutions (p < 0.001). 89.05% of the patients had solely one meningioma surgery, 8.52% two and, 2.43% three or more. The number of surgeries was associated to the grade of malignancy (p < 0.001).
CONCLUSION CONCLUSIONS
The incidence of meningioma surgery increased with age and, peaked at 58.5 years. They were predominantly benign with meningothelial subtype being the most common. However, there was a significant variation of grade 1 subtypes diagnosis among the centres involved. The proportion of grade 2 meningioma significantly grew over the study time, on contrary to malignant meningioma proportion, which remained rare and, stable over time around 2%. Likewise, there was a significant variability of grade 2 meningioma rate among the institutions.

Identifiants

pubmed: 38740641
doi: 10.1007/s00701-024-06093-z
pii: 10.1007/s00701-024-06093-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

214

Investigateurs

G Abi Lahoud (GA)
R Aboukais (R)
V Achim (V)
T Adetchessi (T)
B Aesch (B)
M Agha (M)
N Aghakhani (N)
R Al Hallak (R)
A Albert (A)
S Aldea (S)
M Ali Benali (MA)
Y Ali (Y)
V Allano (V)
M Allaoui (M)
J R Alliez (JR)
F Almairac (F)
N Aouad (N)
F Arthuis (F)
A Ashraf (A)
R Assaker (R)
M Atta (M)
None Augros
J Auque (J)
A Autricque (A)
A Balossier (A)
J L Barat (JL)
Barnoud Croix (B)
M Baroncini (M)
F Barral-Clavel (F)
C Barrey (C)
B Bataille (B)
X Baujat (X)
B Baussart (B)
M Bayram (M)
A Bazin (A)
Y Beaudic (Y)
J Beaurain (J)
K Beccaria (K)
G Bedou (G)
O Bekaert (O)
H Belaid (H)
H Belliard (H)
F Bellow (F)
R Beltechi (R)
M Ben Ismaïl (MB)
A Benazza (A)
A Benbrahi (A)
J Benezech (J)
L Benhaddou-Benkirane (L)
H Benhima (H)
M Benmekhbi (M)
S Bennis (S)
M Berhouma (M)
C Bernard (C)
M H Bernard (MH)
A L Bernat (AL)
J L Berthelot (JL)
G Besson (G)
J B Billant (JB)
R Billon-Grand (R)
A Bitar (A)
C Bizette (C)
J L Blanc (JL)
A Blanquet (A)
T Blauwblomme (T)
S Blond (S)
E Blondet (E)
A L Boch (AL)
S Boetto (S)
H Boissonnet (H)
G Boniface (G)
E Bord (E)
A Borha (A)
C Botella (C)
I Bouali (I)
S Bouazza (S)
R Bougeard (R)
P Bouillot (P)
A Bouras (A)
P Bourgeois (P)
J Y Bousigue (JY)
C Bousquet (C)
O Bousquet (O)
P Bousquet (P)
F Boyer (F)
P Boyer (P)
G Brassier (G)
D Brauge (D)
D Bresson (D)
None Brie
J Brunon (J)
K Buffenoir Billet (KB)
N Buisset (N)
P Cabal (P)
P Caillaud (P)
F Caire (F)
P Cam (P)
C Cao (C)
C Capel (C)
L Capelle (L)
M Cardarelli (M)
L Carlucci (L)
A Carpentier (A)
R Carron (R)
H Cebula (H)
J B Cesari (JB)
A Chabane (A)
S Chabardes (S)
F Chabolle (F)
R Chaix (R)
C Champeaux Depond (C)
E Chan Seng (EC)
D Chaussemy (D)
D Chauvet (D)
P Chaynes (P)
A Chays (A)
J Chazal (J)
S Chibbaro (S)
J P Chirossel (JP)
N Chivoret (N)
M Choukri (M)
T Civit (T)
S Clemenceau (S)
H A Coca (HA)
J Cochereau (J)
G Coll (G)
S Colnat Coulbois (SC)
P Compaore (P)
J Cornelius (J)
P Cornu (P)
D Costache (D)
A Coste (A)
P Coubes (P)
L Crampette (L)
A Cristini (A)
E Cuny (E)
S Curey (S)
A Czorny (A)
G D'acunzi (G)
V D'hardemare (V)
S D'houtaud (S)
A Dagain (A)
P Dam Hieu (PD)
J B Dandine (JB)
I Darie (I)
V Darrouzet (V)
A Dauta (A)
M Dautheribes (M)
P David (P)
B De Germay (B)
F De Rose (F)
T De Saint-Denis (T)
J B Debaux (JB)
B Debono (B)
C Debry (C)
A Decouvelaere (A)
P Decq (P)
O Delalande (O)
M Delhaye (M)
M Delion (M)
J M Delmas (JM)
A Delmotte (A)
P Delpy (P)
C Delsanti (C)
J M Derlon (JM)
S Derrey (S)
C Desenclos (C)
M Desgeorges (M)
A Desplat (A)
N Desse (N)
P Dessi (P)
J Destandau (J)
C Destrieux (C)
B Devaux (B)
E Dezamis (E)
P Dhellemmes (P)
L Di Tommaso (L)
S Diabira (S)
A Diaz (A)
C Dimitriu (C)
R Djedid (R)
M Djindjian (M)
L Do (L)
K Doe (K)
None Donne
G Dorfmuller (G)
D Dorwling-Carter (D)
None Appourchaux
None Daussay
I Delestret (I)
None Ouammou
None Riegel
None Verhulst
G Dran (G)
G Dubois (G)
T Dudoit (T)
H Duffau (H)
H Dufour (H)
T Dufour (T)
R Duhem (R)
R Dulou (R)
B Dumas (B)
J Duntze (J)
T Dupard (T)
M Dupuy (M)
A Durand (A)
None Dussartre
G Dutertre (G)
R Duthel (R)
C Eap (C)
H El Fertit (HE)
S Elouahdani-Hamdi (S)
E Emery (E)
J Engelhardt (J)
C Espagno (C)
P Esposito (P)
R Faguer (R)
T Faillot (T)
W Farah (W)
A Faure (A)
P Faure (P)
S Ferrand Sorbets (SF)
J Fesselet (J)
A Fichten (A)
D Fischer (D)
D Fischer Lokou (DF)
D Fontaine (D)
M J Fotso (MJ)
D Fournier (D)
S Fowo-Ngadjou (S)
P Francois (P)
B Frank (B)
None Frappaz
P Freger (P)
E Freitas Olim (EF)
S Freppel (S)
S Froelich (S)
J-M Fuentes (JM)
S Fuentes (S)
T Gaberel (T)
R Gadan (R)
S Gaillard (S)
F Ganem (F)
C Gantois (C)
None Garnier
M Gay (M)
B George (B)
R Giacomelli (R)
M Gigaud (M)
S Gil Robles (SG)
E Gimbert (E)
C Ginguene (C)
O Goasguen (O)
J Godard (J)
G Godfrin (G)
A Gomez (A)
V Gonzalez Martinez (VG)
G Gouello (G)
S Goutagny (S)
T Graillon (T)
G Gras Combe (GG)
M Grassi (M)
B Grayeli (B)
M Grelat (M)
P Grellier (P)
F Grisoli (F)
J Guarnieri (J)
None Guedon
Y Guegan (Y)
M Guenot (M)
D Guerra Sierra (DG)
E M Gueye (EM)
M Gurshi (M)
J Guyotat (J)
E Haddad (E)
C Haegelen (C)
S Hamdi (S)
O Hamel (O)
A Hamlat (A)
P Hannequin (P)
F Hansen Von Bunau (FH)
O Hatem (O)
G Hayek (G)
A Herbrecht (A)
P Herman (P)
J P Hladky (JP)
X Hoarau (X)
D Hoffmann (D)
C Horodyckid (C)
J C Huot (JC)
G Iakovlev (G)
R Ibrahim (R)
B Irthum (B)
R Ischac (R)
T Jacquesson (T)
G Jacquet (G)
S James (S)
M Jan (M)
B Jarraya (B)
V Jecko (V)
E Jouanneau (E)
A Joud (A)
T Julhien (T)
H Kaddoum (H)
M Kalamarides (M)
C Karachi (C)
H Katrangi (H)
J M Kaya (JM)
P Kehrli (P)
Y Keravel (Y)
M Khalfallah (M)
I Khalil (I)
T Khalil (T)
K Khouri (K)
S Khouri (S)
J C Kleiber (JC)
O Klein (O)
A Koudsie (A)
W Krichen (W)
A Kuzeawu (A)
G Laborde (G)
L Laccoureye (L)
J Lagarrigue (J)
D Laguerre (D)
M Lahiani (M)
M A Lahlou (MA)
O Langlois (O)
F Lapierre (F)
C Lapras (C)
None Lascu
O Launay (O)
J P Lavieille (JP)
M Le Corre (M)
None Le Fay
M Le Franc (M)
C Le Guerinel (C)
P Lefevre (P)
D Legars (D)
J P Lejeune (JP)
J J Lemaire (JJ)
G Lena (G)
J F Lepeintre (JF)
B Leriche (B)
H A Leroy (HA)
J P Lescure (JP)
None Leston
M Leveque (M)
D Liguoro (D)
E Lioret (E)
A Listrat (A)
F Litre (F)
S Litrico (S)
H Loiseau (H)
M Lonjon (M)
N Lonjon (N)
M Lopes (M)
J E Loret (JE)
G Lot (G)
E Louis (E)
A Louveau (A)
V Lubrano (V)
F Lucas (F)
O Lucas (O)
G Lungu (G)
M Dorel Le-The (MD)
J Maarrawi (J)
C Magheru (C)
E Magro (E)
J Maheut-Lourmiere (J)
K Mahla (K)
A Maillard (A)
M Maingot (M)
None Maisonneuve
D Maitrot (D)
O Makiese (O)
S Mandat (S)
E Mandonnet (E)
R Manet (R)
None Mansour
N Manzo (N)
J C Marchal (JC)
J P Marie (JP)
P Marinho (P)
D Marnet (D)
A Marniche (A)
C Martin (C)
S Martin (S)
A Melot (A)
D Memia Zolo (DM)
VMendes Martins (V)
D Menegalli (D)
P Menei (P)
P Mercier (P)
I Merlot (I)
P Mertens (P)
M Messerer (M)
P Metellus (P)
V Meyer-Bisch (V)
M Meyer (M)
J F Mineo (JF)
E Mireau (E)
O Mollier (O)
P Monteil (P)
R Montessuy (R)
A Mora (A)
X Morandi (X)
S Morar (S)
C Moraru (C)
J J Moreau (JJ)
None Morel
C Morel (C)
J Mortada (J)
K Mostofi (K)
C Mottolese (C)
K Moubarak (K)
L Mourier (L)
E Moyse (E)
B Muckensturm (B)
E Nader (E)
F Nahas (F)
H Namaki (H)
K Narantuya (K)
F Nataf (F)
S Navarro (S)
None Nebab
J P Nguyen (JP)
T Njee (T)
L Nogues (L)
R Noudel (R)
A Nouet (A)
R Nseir (R)
C Nuti (C)
M Orabi (M)
D Orenstein (D)
Y Ouammou (Y)
N Ouerchefani (N)
P Gauchez (P)
P Page (P)
S Palfi (S)
O Palombi (O)
P Paquis (P)
G Paradot Mouton (GP)
F Parker (F)
J G Passagia (JG)
G Paternoster (G)
G Pech Gourg (GP)
I Pelissou-Guyotat (I)
J Peltier (J)
P Pencalet (P)
P Pencalet (P)
G Penchet (G)
J C Peragut (JC)
A Perez (A)
P Pernot (P)
G Perrin (G)
H Person (H)
P Peruzzi (P)
A Petit (A)
D Petit (D)
M Peyre (M)
N J G Pimenta (NJG)
C Pinelli (C)
B Piot (B)
B Plas (B)
J Y Plas (JY)
G Polo (G)
C Popa (C)
C P Popa (CP)
None Porhiel
V Porhiel (V)
A Postelnicu (A)
B Pouit (B)
P Gosset (P)
None Vaneecloo
None Vincent
J M Privat (JM)
F Proust (F)
A S Pruvot-Occean (AS)
S Puget (S)
C Rabehenoina (C)
M Rabhi (M)
O Ragragui (O)
T Rambolarimanana (T)
None Ranchere
S Raoul (S)
D Rasendrarijao (D)
F Rech (F)
A Redondo (A)
J Regis (J)
V Reina (V)
J Remond (J)
None Remond
Y Reynier (Y)
N Reyns (N)
A C Ricci Franchi (ACR)
None Richet
A Richet (A)
F Ricouart (F)
T Riem (T)
L Riffaud (L)
P Rigoard (P)
G Robert (G)
R Robert (R)
A Robier (A)
M-A Rodriguez (MA)
V Rodriguez (V)
M Ros (M)
G Roualdes (G)
V Roualdes (V)
A Rougier (A)
T Roujeau (T)
P Rousseaux (P)
F Roux (F)
F X Roux (FX)
M Rue (M)
J Sabatier (J)
P Sabatier (P)
M Sabbah (M)
O Sacko (O)
C Sainte-Rose (C)
L Sakka (L)
C Salaud (C)
H Salle (H)
B Salmon (B)
F San Galli (FS)
J M Sankaredja (JM)
J L Sautreaux (JL)
None Sauvaget
F Sauvaget (F)
P Scarone (P)
D Scavarda (D)
B Scherpereel (B)
E Schmidt (E)
F Segnarbieux (F)
E Seigneuret (E)
R Seizeur (R)
L Selek (L)
J P Sichez (JP)
S Sid Hamed (SS)
F Signorelli (F)
B Silhouette (B)
A Simon (A)
E Simon (E)
A Simonneau (A)
D Sinardet (D)
M Sindou (M)
M Sleiman (M)
J C Sol (JC)
O Soumare (O)
A Srour (A)
R Srour (R)
H Staquet (H)
J Stecken (J)
I Stella (I)
O Sterkers (O)
B Stilhart (B)
A Szathmari (A)
S Taha (S)
S Tazi (S)
J Ternier (J)
O Testa (O)
M C Tetard (MC)
E Theret (E)
J B Thiebaut (JB)
L Thines (L)
C Thomas (C)
J M Thomassin (JM)
L Tigan (L)
A Timofeev (A)
A C Tobenas Dujardin (ACT)
J Todeschi (J)
V Tonnelle (V)
H Tourneux (H)
P Toussaint (P)
A Touta (A)
P Tran Ba Huy (PTB)
N Travers (N)
M Tremoulet (M)
B Turak (B)
B Vallee (B)
P Vally (P)
R Van Effenterre (R)
Y Van Raay (Y)
F Vassal (F)
M Vassal (M)
S Velut (S)
J Vidal (J)
J R Vignes (JR)
L Villette (L)
F Vincentelli Ange (FV)
M Vinchon (M)
L Vinikoff (L)
J Voirin (J)
M Wager (M)
Y Yordanova (Y)
F Zaïri (F)
M Zerah (M)
J Ziyadeh (J)
C Adam (C)
H Adle-Biassette (H)
None Adreux
None Afo
None Ale
M P Algros (MP)
None Am
C Amat (C)
F Andreiuolo (F)
F Ansart (F)
F Arbez-Gindre (F)
F Arbion (F)
None Arrivets
C Attencourt (C)
M H Aubriot Lorton (MHA)
G Averous (G)
J Aziza (J)
B P Badsi (BP)
A C Baglin (AC)
P Baldet (P)
None Bar
C Barbey (C)
A Bay (A)
C Bazille I Bedgedjian (CBI)
P Bedossa (P)
None Ben
S Benabidallah (S)
A Benali (A)
A M Bergemer Fouquet (AMB)
M A Bergouignan (MA)
C Bernard-Decot (C)
M Bernier (M)
C Bertocchi (C)
F Beuvon (F)
F Bielle (F)
C Billotet (C)
P Birembaut (P)
S Bisiau (S)
C Blechet (C)
L Bondoin (L)
C Bonneau (C)
G Bonyhay (G)
S Bordier (S)
None Boudjadi
C Boulagnon-Rombi (C)
J Boutonnat (J)
C Bouvier (C)
E Brambilla (E)
D Branquet (D)
F Breibach (F)
A Bressenot (A)
C Broche (C)
A Brouchet (A)
J P Brouland (JP)
P Brousset (P)
None Cabrol
V Cahn (V)
P Calvet (P)
J Camo (J)
P Camparo (P)
C Capuani (C)
E Cassagnau (E)
J Casse (J)
D Cathelineau (D)
S Caulet (S)
P Caveriviere (P)
D Cazals-Hatem (D)
M L Chambonniere (ML)
F Chapon (F)
None Chapt-Zalcman
F Charlotte (F)
D Chatelain (D)
M P Chenard (MP)
None Chevalier
D C Chiforeanu (DC)
F Chretien (F)
C Christov (C)
A Clairotte (A)
C Cohen (C)
V Conan-Charlet (V)
None Concha
C Cordonnier (C)
B Cormier (B)
K Costa (K)
S Costa (S)
N Costes-Charlet (N)
V Costes (V)
A Coulon (A)
A Couvelard (A)
A Croue (A)
T Cruel (T)
None Dag
M Danjoux (M)
D Darrasse (D)
C Daumas-Duport (C)
None Del
M Delage Corre (MD)
None Delalande
C Delfour (C)
C Delfour (C)
M B Delisle (MB)
M Delsol (M)
M Denis-Musquer (M)
L Deschamps (L)
V Desestret (V)
M Desrousseaux (M)
M D Diebold (MD)
A V Donsbeck (AV)
F Renaud (F)
N Dreux (N)
None Droy-Dupre
G Dubost (G)
None Duchesne
M Duchesne (M)
H Ducoin (H)
O Dudez (O)
I Duga (I)
J M Dumollard (JM)
L Durand (L)
C Dusorbier (C)
None Dusserre
H Duval (H)
S Eimer (S)
W El Alami-Thomas (WE)
Y Elouaret (Y)
G Escourrou (G)
C Etchandy (C)
R P Eyremandi (RP)
F Chretien (F)
None Fabrice
C Fallet-Bianco (C)
B Faroy Menciere (BF)
M Felce Dachez (MF)
S Felix (S)
C Fernandez (C)
F Fetissof (F)
C Feutry (C)
C Fleury (C)
A Fontaine (A)
F Forest (F)
P Fornes (P)
B Fouet (B)
M Fregeville (M)
G Fromont (G)
C Gaspard (C)
G Gauchotte (G)
G Gay (G)
C Godfraind (C)
M F Gontier (MF)
S Gonzalez (S)
J M Goujon (JM)
F Gray (F)
P Gros (P)
P J Guillou (PJ)
None Guiry
J M Harimenshi (JM)
A Heitzmann (A)
D Henin (D)
V Hennequin (V)
M F Heymann (MF)
J F Ikoli (JF)
L Istier (L)
J B Jac (JB)
J F Jazeron (JF)
None Jentet
A Jouvet (A)
C Kandel-Aznar (C)
B Kantelip (B)
J L Kemeny (JL)
O Kerdraon (O)
R Kerdraon (R)
H P Kermanac (HP)
H P Kermanac (HP)
A Khaddage (A)
I Kleinclaus (I)
S Krzisch (S)
M Kujas (M)
E L (E)
F Labrousse (F)
C Lacroix (C)
L Lamant (L)
S Lantuejoul (S)
A Laquerriere (A)
M C Laurent-Yriarte (MC)
C Laurent (C)
F Le Gall (F)
M Le Houcq (M)
C Le Naoures-Meal (C)
E Lechapt (E)
F Leclair (F)
None Leclercq
C Lecointre (C)
F Leger (F)
S Lepreux (S)
F Lerintiu (F)
P Levillain (P)
B Lhermitte (B)
A Liprandi (A)
F Llamas (F)
K Llinares (K)
E Longchampt (E)
D Loussouarn (D)
M Andraud (M)
M Machet (M)
F Maitre (F)
E Majek-Zakine (E)
A M Manent (AM)
A Maran (A)
L Marcellin (L)
A Marchal (A)
N Marcon (N)
P Marcorelles (P)
A Mareel (A)
C Marguet (C)
B Marie (B)
L Martin (L)
Mathieu Mag Gallo (MM)
A Maues De Paula (AM)
C A Maurage (CA)
None Maz
C Mazerolles (C)
A Mensah (A)
E Mergey (E)
D Meyronet (D)
None Mez
S Michalak (S)
J M Michels (JM)
P Michenet (P)
J F Michiels (JF)
I Mihlai Marcela (IM)
S Milin (S)
C Miquel (C)
M Mohr (M)
K Mokhtari (K)
C Mondon (C)
Monegier Du Sorbier (M)
I Morand Dusserre (IM)
A Moreau (A)
M Moreau (M)
None Mos
J F Mosnier (JF)
C Musso Rigal (CM)
None Myrmel
K S Myrmel (KS)
N Guyen (N)
A Neuville (A)
A Oksman (A)
M A Onea (MA)
S P (S)
M Pages (M)
J Palasse (J)
M Patey (M)
J F Pellissier (JF)
M Peoc'h (M)
T Petrella (T)
A Philippe (A)
J Pialat (J)
M Pluot (M)
M Polivka (M)
I Pommepuy (I)
None Aubert
G Fromont (G)
M Pradere (M)
F Projetti (F)
M Quintana (M)
I Quintin (I)
M L Quintyn-Ranty (ML)
J Ramos (J)
E Ranfaing (E)
D Raoux (D)
None Raynaud
P Raynaud (P)
R Reis Borges (RR)
F Renaud (F)
L Renjard (L)
J Reyre (J)
P Richard (P)
S Richard (S)
V Rigau (V)
F Ringenbach (F)
B Riviere (B)
P Roger (P)
I Rouquette (I)
A Rousseau (A)
M C Rousselet (MC)
C Rousselot (C)
J C Sabourin (JC)
None Saguet
S Saïkali (S)
M C Saint-Paul (MC)
G Saint Pierre (GS)
C Salon (C)
None Sam
None Samaison
L Samaison (L)
C Savin (C)
J Selves (J)
None Seurat
H Sevestre (H)
C Singeorzan (C)
R Sorbara (R)
R Soulard (R)
J B Souraud (JB)
P Sto Straub (PS)
N Streichenberger (N)
N Sturm (N)
V Szablewski (V)
None Tal
None Talagas
M Talagas (M)
None Taris
M Taris (M)
A Tauziede-Espariat (A)
None Thi
C Toquet (C)
M C Tortel (MC)
G Toubeau (G)
E Tournier (E)
E Uro-Coste (E)
S Valmary Degano (SV)
F Vandenbos (F)
P Varlet (P)
A Vasiljevic (A)
L Veresezan (L)
P Verhulst (P)
G Viennet (G)
J M Vignaud (JM)
C Vigouroux (C)
C Villa (C)
Virginie Baras (V)
A Vital (A)
A Warter (A)
M Wassef (M)
N Weinbreck (N)
M Yacoub (M)
D Zachar (D)
M Zidane Marinnes (MZ)

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Références

Ammendola S, Bariani E, Eccher A, Capitanio A, Ghimenton C, Pantanowitz L, Parwani A, Girolami I, Scarpa A, Barresi V (2021) The histopathological diagnosis of atypical meningioma: Glass slide versus whole slide imaging for grading assessment. Virchows Arch 478(4):747–756
doi: 10.1007/s00428-020-02988-1 pubmed: 33305338
Baldi I, Gruber A, Alioum A et al (2011) Descriptive epidemiology of CNS tumors in france: Results from the gironde registry for the period 2000–2007. Neuro Oncol 13(12):1370–1378
doi: 10.1093/neuonc/nor120 pubmed: 21980160 pmcid: 3223087
Bauchet L, Rigau V, Mathieu-Daudé H et al (2007) French brain tumor data bank: Methodology and first results on 10,000 cases. J Neurooncol 84(2):189–199
doi: 10.1007/s11060-007-9356-9 pubmed: 17431547
Brokinkel B, Hess K, Mawrin C (2017) Brain invasion in meningiomas—clinical considerations and impact of neuropathological evaluation: A systematic review. Neuro Oncol 19(10):1298–1307
doi: 10.1093/neuonc/nox071 pubmed: 28419308 pmcid: 5596167
Champeaux-Depond C, Constantinou P, Tuppin P, Resche-Rigon M, Weller J (2022) Relative survival after meningioma surgery. A french nationwide population-based cohort study. Br J Neurosurg 1–7. https://doi.org/10.1080/02688697.2022.2159925
Champeaux-Depond C, Constantinou P, Weller J (2021) Cause-specific survival after meningioma surgery: a nationwide population-based competing risk study. World Neurosurg 146:e67–e75
doi: 10.1016/j.wneu.2020.10.012 pubmed: 33096279
Champeaux-Depond C, Penet N, Weller J, Huec J-CL, Jecko V (2022) Functional outcome after spinal meningioma surgery. A nationwide population-based study Neurospine 19(1):96–107
pubmed: 35378584
Champeaux-Depond C, Weller J (2021) Outcome after protontherapy for progression or recurrence of surgically treated meningioma. Brain Tumor Res Treat 9(2):46–57
doi: 10.14791/btrt.2021.9.e9 pubmed: 34725984 pmcid: 8561229
Champeaux-Depond C, Weller J, Constantinou P, Tuppin P, Froelich S (2022) Five-year cause-specific survival after meningioma surgery. A nationwide population-based study. Neurochirurgie 68(3):280–288
doi: 10.1016/j.neuchi.2021.11.003 pubmed: 34906556
Champeaux-Depond C, Weller J, Froelich S, Resche-Rigon M (2021) A nationwide population-based study on overall survival after meningioma surgery. Cancer Epidemiol 70:101875
doi: 10.1016/j.canep.2020.101875 pubmed: 33360358
Champeaux-Depond C, Weller J, Froelich S, Sartor A (2021) Cyproterone acetate and meningioma: A nationwide-wide population based study. J Neurooncol 151(2):331–338
doi: 10.1007/s11060-020-03672-9 pubmed: 33394263
Champeaux-Depond C, Weller J, Resche-Rigon M (2020) Neurofibromatosis type 2: A nationwide population-based study focused on survival after meningioma surgery. Clin Neurol Neurosurg 198:106236
doi: 10.1016/j.clineuro.2020.106236 pubmed: 33002675
Champeaux C, Weller J, Katsahian S (2019) Epidemiology of meningiomas. A nationwide study of surgically treated tumours on french medico-administrative data. Cancer Epidemiol 58:63–70
doi: 10.1016/j.canep.2018.11.004 pubmed: 30481723
Darlix A, Zouaoui S, Rigau V et al (2017) Epidemiology for primary brain tumors: A nationwide population-based study. J Neurooncol 131(3):525–546
doi: 10.1007/s11060-016-2318-3 pubmed: 27853959
Dolecek TA, Dressler EVM, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015) Epidemiology of meningiomas post-public law 107–206: The benign brain tumor cancer registries amendment act. Cancer 121(14):2400–2410
doi: 10.1002/cncr.29379 pubmed: 25872752
Holleczek B, Zampella D, Urbschat S, Sahm F, von Deimling A, Oertel J, Ketter R (2019) Incidence, mortality and outcome of meningiomas: A population-based study from germany. Cancer Epidemiol 62:101562
doi: 10.1016/j.canep.2019.07.001 pubmed: 31325769
Jecko V, Weller J, Houston D, Champeaux-Depond C (2022) Epidemiology and survival after spinal meningioma surgery: A nationwide population-based study. Asian Spine J 16(6):865–873
doi: 10.31616/asj.2021.0213 pubmed: 35051328 pmcid: 9827205
Kshettry VR, Ostrom QT, Kruchko C, Al-Mefty O, Barnett GH, Barnholtz-Sloan JS (2015) Descriptive epidemiology of world health organization grades II and III intracranial meningiomas in the united states. Neuro Oncol 17(8):1166–1173
doi: 10.1093/neuonc/nov069 pubmed: 26008603 pmcid: 4490879
Lang TA, Altman DG (2015) Basic statistical reporting for articles published in biomedical journals: The “Statistical Analyses and Methods in the Published Literature” or the SAMPL Guidelines. Int J Nurs Stud 52(1):5–9
doi: 10.1016/j.ijnurstu.2014.09.006 pubmed: 25441757
Li H-Y, Ying Y-Z, Zheng D, Dong G-H, Zhang G-B, Liu X-M, Lin S, Ren X-H, Jiang Z-L (2023) Is brain invasion sufficient as a stand-alone criterion for grading atypical meningioma? J Neurosurg 139(4):953–964
doi: 10.3171/2023.2.JNS222751 pubmed: 37561905
Loiseau H, Huchet A, Rué M, Cowppli-Bony A, Baldi I (2009) Epidemiology of primary brain tumor. Rev Neurol (Paris) 165(8):650–670
doi: 10.1016/j.neurol.2009.04.002 pubmed: 19446856
Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol 23(8):1231–1251
doi: 10.1093/neuonc/noab106 pubmed: 34185076 pmcid: 8328013
Ng S, Zouaoui S, Bessaoud F et al (2020) An epidemiology report for primary central nervous system tumors in adolescents and young adults: A nationwide population-based study in france, 2008–2013. Neuro Oncol 22(6):851–863
doi: 10.1093/neuonc/noz227 pubmed: 31796950
Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, Barnholtz-Sloan JS (2022) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2015–2019. Neuro Oncol 24:v1–v95
doi: 10.1093/neuonc/noac202 pubmed: 36196752 pmcid: 9533228
Picart T, Dumot C, Guyotat J et al (2022) Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: Lessons from a series of 291 cases. Neurosurg Rev 45(4):2797–2809
doi: 10.1007/s10143-022-01792-6 pubmed: 35488071
R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
Rigau V, Zouaoui S, Mathieu-Daudé H et al (2011) French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol 21(6):633–644
doi: 10.1111/j.1750-3639.2011.00491.x pubmed: 21554472 pmcid: 8094058
Rogers L, Gilbert M, Vogelbaum MA (2010) Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol 99(3):393–405
doi: 10.1007/s11060-010-0343-1 pubmed: 20740303
Rogers CL, Perry A, Pugh S et al (2016) Pathology concordance levels for meningioma classification and grading in NRG oncology RTOG trial 0539. Neuro Oncol 18(4):565–574
doi: 10.1093/neuonc/nov247 pubmed: 26493095
RStudio Team (2015) RStudio: Integrated development environment for r. RStudio Inc, Boston
Song D, Xu D, Han H, Gao Q, Zhang M, Wang F, Wang G, Guo F (2021) Postoperative adjuvant radiotherapy in atypical meningioma patients: A meta-analysis study. Front Oncol 11:787962
doi: 10.3389/fonc.2021.787962 pubmed: 34926303 pmcid: 8674463
Thuijs NB, Uitdehaag BMJ, Van Ouwerkerk WJR, van der Valk P, Vandertop WP, Peerdeman SM (2012) Pediatric meningiomas in the netherlands 1974–2010: A descriptive epidemiological case study. Childs Nerv Syst 28(7):1009–1015
doi: 10.1007/s00381-012-1759-z pubmed: 22543431 pmcid: 3376254
Tuppin P, Rudant J, Constantinou P et al (2017) Value of a national administrative database to guide public decisions: From the système national d’information interrégimes de l’assurance maladie (SNIIRAM) to the système national des données de santé (SNDS) in france. Rev Epidemiol Sante Publique 65(Suppl 4):S149–S167
doi: 10.1016/j.respe.2017.05.004 pubmed: 28756037
Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D (2005) The accuracy of meningioma grading: A 10-year retrospective audit. Neuropathol Appl Neurobiol 31(2):141–149
doi: 10.1111/j.1365-2990.2004.00621.x pubmed: 15771707
Woehrer A, Hackl M, Waldhör T et al (2014) Relative survival of patients with non-malignant central nervous system tumours: A descriptive study by the austrian brain tumour registry. Br J Cancer 110(2):286–296
doi: 10.1038/bjc.2013.714 pubmed: 24253501
Wöhrer A, Waldhör T, Heinzl H et al (2009) The austrian brain tumour registry: A cooperative way to establish a population-based brain tumour registry. J Neurooncol 95(3):401–411
doi: 10.1007/s11060-009-9938-9 pubmed: 19562257
Youngblood MW, Duran D, Montejo JD et al (2019) Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg 1–10. https://doi.org/10.3171/2019.8.JNS191266
Zouaoui S, Rigau V, Mathieu-Daudé H et al (2012) French brain tumor database: General results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58(1):4–13
doi: 10.1016/j.neuchi.2012.01.004 pubmed: 22385800

Auteurs

Charles Champeaux Depond (CC)

Department of Neurosurgery, Hôpital Privé Clairval - Ramsay Santé, 317 Bd de Redon, 13009, Marseille, France. Charles.ChampeauxDepond@gmail.com.

Sonia Zouaoui (S)

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.

Amélie Darlix (A)

Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Medical Oncology Department, Institut du Cancer de Montpellier, University of Montpellier, 34298, Montpellier, France.

Valérie Rigau (V)

Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Department of Pathology, Gui-de-Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.

Hélène Mathieu-Daudé (H)

Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.

Fabienne Bauchet (F)

Department of Epidemiology, French Brain Tumour Database, GNOLR, Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.

Mohamed Khettab (M)

Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Medical Oncology Unit, CHU de La Réunion, Université de La Réunion, 97410, Saint Pierre, France.

Brigitte Trétarre (B)

Registre Des Tumeurs de L'Hérault, ICM, 34298, Montpellier cedex 5, France.

Dominique Figarella-Branger (D)

Institut de Neurophysiopathologie, Service d'Anatomie Pathologique Et de Neuropathologie, Aix-Marseille University, APHM, CNRS, INP, CHU Timone, 13005, Marseille, France.

Luc Taillandier (L)

Department of Neurology, University Hospital of Nancy, Nancy, France.

Julien Boetto (J)

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.
Paris Brain Institute, Sorbonne Université, CRICM INSERM U1127 CNRS UMR 7225, 75013, Paris, France.

Johan Pallud (J)

Service de Neurochirurgie, GHU Paris Psychiatrie Et Neurosciences, Site Sainte Anne, 75014, Paris, France.
Université Paris Cité, Institute of Psychiatry and Neuroscience of Paris, INSERM U1266, 75014, Paris, France.

Ilyess Zemmoura (I)

Neurosurgery Department, CHRU de Tours, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.

Pierre-Hugues Roche (PH)

Neurosurgery Department, CHRU de Tours, Tours, France.
UMR 1253, iBrain, Université de Tours, Inserm, Tours, France.
Service de Neurochirurgie de L'hôpital Nord, APHM - AMU, Marseille, France.

Luc Bauchet (L)

Department of Neurosurgery, Gui de Chauliac Hospital, Montpellier University Medical Center, 34295, Montpellier cedex 5, France.
Institut de Génomique Fonctionnelle (IGF), University of Montpellier, CNRS, INSERM, 34094, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH